nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—adrenal medulla—adrenal gland cancer	0.156	0.495	CbGeAlD
Amlexanox—S100A13—gonad—adrenal gland cancer	0.0202	0.0643	CbGeAlD
Amlexanox—S100A12—pituitary gland—adrenal gland cancer	0.0195	0.0618	CbGeAlD
Amlexanox—S100A13—adrenal gland—adrenal gland cancer	0.0176	0.056	CbGeAlD
Amlexanox—S100A12—adrenal gland—adrenal gland cancer	0.0174	0.0553	CbGeAlD
Amlexanox—FGF1—cardiac atrium—adrenal gland cancer	0.0124	0.0395	CbGeAlD
Amlexanox—FGF1—pituitary gland—adrenal gland cancer	0.0121	0.0386	CbGeAlD
Amlexanox—PDE4D—adrenal gland—adrenal gland cancer	0.0116	0.0369	CbGeAlD
Amlexanox—FGF1—adrenal gland—adrenal gland cancer	0.0108	0.0345	CbGeAlD
Amlexanox—PDE4A—adrenal gland—adrenal gland cancer	0.0103	0.0326	CbGeAlD
Amlexanox—PDE4B—gonad—adrenal gland cancer	0.00702	0.0223	CbGeAlD
Amlexanox—PDE4B—cardiac atrium—adrenal gland cancer	0.00701	0.0223	CbGeAlD
Amlexanox—PDE4B—pituitary gland—adrenal gland cancer	0.00685	0.0218	CbGeAlD
Amlexanox—PDE4B—adrenal gland—adrenal gland cancer	0.00612	0.0195	CbGeAlD
Amlexanox—FGF1—DAP12 interactions—BAD—adrenal gland cancer	0.00125	0.00183	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—BAD—adrenal gland cancer	0.00125	0.00183	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	0.00125	0.00183	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—BAD—adrenal gland cancer	0.00124	0.00181	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	0.00123	0.0018	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—BAD—adrenal gland cancer	0.00123	0.00179	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—BRAF—adrenal gland cancer	0.00122	0.00179	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CDC42—adrenal gland cancer	0.00122	0.00178	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00118	0.00172	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—EGFR—adrenal gland cancer	0.00116	0.0017	CbGpPWpGaD
Amlexanox—FGF1—Immune System—SH3KBP1—adrenal gland cancer	0.00116	0.0017	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—BAD—adrenal gland cancer	0.00116	0.00169	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00115	0.00167	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00114	0.00167	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—BRAF—adrenal gland cancer	0.00114	0.00166	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00113	0.00165	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00113	0.00164	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00113	0.00164	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.00111	0.00162	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0011	0.0016	CbGpPWpGaD
Amlexanox—FGF1—Disease—SH3KBP1—adrenal gland cancer	0.00107	0.00157	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00107	0.00156	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00106	0.00154	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00105	0.00153	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—EGFR—adrenal gland cancer	0.00105	0.00153	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00105	0.00153	CbGpPWpGaD
Amlexanox—IL3—Immune System—PRKACA—adrenal gland cancer	0.00105	0.00153	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—EGFR—adrenal gland cancer	0.00102	0.00149	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00102	0.00149	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00102	0.00149	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—EGFR—adrenal gland cancer	0.00102	0.00148	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.00101	0.00147	CbGpPWpGaD
Amlexanox—FGF1—Disease—ZNRF3—adrenal gland cancer	0.00101	0.00147	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000998	0.00146	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—adrenal gland cancer	0.000992	0.00145	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000988	0.00144	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GNRHR—adrenal gland cancer	0.000984	0.00144	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00098	0.00143	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000971	0.00142	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000968	0.00141	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000967	0.00141	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00095	0.00139	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TSHR—adrenal gland cancer	0.000942	0.00137	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000937	0.00137	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000933	0.00136	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000928	0.00135	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000915	0.00134	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TSHR—adrenal gland cancer	0.00089	0.0013	CbGpPWpGaD
Amlexanox—IL3—Immune System—CDC42—adrenal gland cancer	0.000887	0.00129	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MEN1—adrenal gland cancer	0.000886	0.00129	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000879	0.00128	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000871	0.00127	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000867	0.00127	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GNRHR—adrenal gland cancer	0.000867	0.00126	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000863	0.00126	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00086	0.00126	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—BAD—adrenal gland cancer	0.000854	0.00125	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—BAD—adrenal gland cancer	0.000852	0.00124	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000847	0.00124	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PRKACA—adrenal gland cancer	0.000838	0.00122	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PRKACA—adrenal gland cancer	0.000823	0.0012	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000819	0.00119	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000808	0.00118	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000806	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PRKACA—adrenal gland cancer	0.00079	0.00115	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TSHR—adrenal gland cancer	0.000784	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.000784	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—BRAF—adrenal gland cancer	0.000777	0.00113	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000776	0.00113	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000758	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000751	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	0.00075	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00075	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000738	0.00108	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000733	0.00107	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CDC42—adrenal gland cancer	0.000711	0.00104	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000707	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—EGFR—adrenal gland cancer	0.000705	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—EGFR—adrenal gland cancer	0.000701	0.00102	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000698	0.00102	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CDC42—adrenal gland cancer	0.000698	0.00102	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—EGFR—adrenal gland cancer	0.000694	0.00101	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000688	0.001	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000685	0.001	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	0.000684	0.000999	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000677	0.000988	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000676	0.000987	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDC42—adrenal gland cancer	0.00067	0.000978	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000655	0.000955	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	0.000653	0.000953	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—EGFR—adrenal gland cancer	0.000653	0.000953	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.000653	0.000953	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—EGFR—adrenal gland cancer	0.000647	0.000945	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.000642	0.000936	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—EGFR—adrenal gland cancer	0.000639	0.000932	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000639	0.000932	CbGpPWpGaD
Amlexanox—FGF1—Disease—SPRY2—adrenal gland cancer	0.000632	0.000923	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—POMC—adrenal gland cancer	0.000625	0.000912	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000622	0.000908	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00062	0.000904	CbGpPWpGaD
Amlexanox—IL3—Immune System—BAD—adrenal gland cancer	0.000619	0.000903	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000615	0.000897	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000608	0.000887	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—EGFR—adrenal gland cancer	0.000605	0.000882	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TSHR—adrenal gland cancer	0.000604	0.000881	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000596	0.00087	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000594	0.000867	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GNRH1—adrenal gland cancer	0.00059	0.00086	CbGpPWpGaD
Amlexanox—FGF1—Disease—MEN1—adrenal gland cancer	0.000579	0.000846	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000579	0.000844	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDC42—adrenal gland cancer	0.000574	0.000837	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00057	0.000832	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000568	0.000828	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MEN1—adrenal gland cancer	0.000568	0.000828	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000562	0.000821	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000561	0.000819	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CTNNB1—adrenal gland cancer	0.000561	0.000818	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF2—adrenal gland cancer	0.000553	0.000807	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GNAS—adrenal gland cancer	0.000548	0.0008	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000542	0.000792	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CDC42—adrenal gland cancer	0.000542	0.00079	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SPRY2—adrenal gland cancer	0.000539	0.000787	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000535	0.00078	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TSHR—adrenal gland cancer	0.000526	0.000767	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000525	0.000766	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000519	0.000758	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GNAS—adrenal gland cancer	0.000518	0.000755	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—adrenal gland cancer	0.000517	0.000754	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000516	0.000753	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000516	0.000752	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000513	0.000749	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000502	0.000732	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TSHR—adrenal gland cancer	0.0005	0.00073	CbGpPWpGaD
Amlexanox—S100A12—Immune System—BAD—adrenal gland cancer	0.000496	0.000724	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MEN1—adrenal gland cancer	0.000494	0.000721	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000493	0.000719	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—BAD—adrenal gland cancer	0.000487	0.00071	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000484	0.000707	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PRKACA—adrenal gland cancer	0.000479	0.000699	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000477	0.000696	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000475	0.000693	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MEN1—adrenal gland cancer	0.00047	0.000686	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—BAD—adrenal gland cancer	0.000468	0.000682	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TSHR—adrenal gland cancer	0.000463	0.000675	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TERT—adrenal gland cancer	0.00046	0.000671	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000456	0.000665	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—EGFR—adrenal gland cancer	0.000445	0.000649	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EGFR—adrenal gland cancer	0.000444	0.000648	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000443	0.000646	CbGpPWpGaD
Amlexanox—FGF1—Disease—PRKACA—adrenal gland cancer	0.000442	0.000645	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000441	0.000643	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MEN1—adrenal gland cancer	0.000435	0.000635	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000433	0.000632	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TSHR—adrenal gland cancer	0.000432	0.00063	CbGpPWpGaD
Amlexanox—IL3—Immune System—CTNNB1—adrenal gland cancer	0.000407	0.000594	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDC42—adrenal gland cancer	0.000406	0.000593	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MEN1—adrenal gland cancer	0.000406	0.000592	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—BAD—adrenal gland cancer	0.0004	0.000584	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—POMC—adrenal gland cancer	0.0004	0.000584	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000384	0.00056	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000377	0.00055	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDC42—adrenal gland cancer	0.000375	0.000547	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—POMC—adrenal gland cancer	0.000369	0.000539	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDC42—adrenal gland cancer	0.000368	0.000536	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000365	0.000533	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—BRAF—adrenal gland cancer	0.000364	0.000532	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000359	0.000524	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF2—adrenal gland cancer	0.000354	0.000517	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000353	0.000515	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GNAS—adrenal gland cancer	0.000351	0.000512	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—POMC—adrenal gland cancer	0.000348	0.000508	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000343	0.0005	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000338	0.000493	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000332	0.000485	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—POMC—adrenal gland cancer	0.000332	0.000484	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CTNNB1—adrenal gland cancer	0.000326	0.000476	CbGpPWpGaD
Amlexanox—IL3—Immune System—EGFR—adrenal gland cancer	0.000323	0.000471	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CTNNB1—adrenal gland cancer	0.00032	0.000467	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDC42—adrenal gland cancer	0.00032	0.000467	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00031	0.000452	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF2—adrenal gland cancer	0.000308	0.00045	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—POMC—adrenal gland cancer	0.000307	0.000448	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GNAS—adrenal gland cancer	0.000306	0.000446	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDC42—adrenal gland cancer	0.000305	0.000444	CbGpPWpGaD
Amlexanox—FGF1—Disease—TERT—adrenal gland cancer	0.000301	0.000439	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000298	0.000435	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TERT—adrenal gland cancer	0.000295	0.00043	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF2—adrenal gland cancer	0.000294	0.000428	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GNAS—adrenal gland cancer	0.000291	0.000425	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000284	0.000414	CbGpPWpGaD
Amlexanox—FGF1—Immune System—BAD—adrenal gland cancer	0.000284	0.000414	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDC42—adrenal gland cancer	0.000282	0.000411	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF2—adrenal gland cancer	0.000272	0.000396	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GNAS—adrenal gland cancer	0.000269	0.000393	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000263	0.000384	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDC42—adrenal gland cancer	0.000263	0.000383	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000263	0.000383	CbGpPWpGaD
Amlexanox—FGF1—Disease—BAD—adrenal gland cancer	0.000262	0.000382	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EGFR—adrenal gland cancer	0.000259	0.000377	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TERT—adrenal gland cancer	0.000257	0.000375	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—BAD—adrenal gland cancer	0.000256	0.000374	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EGFR—adrenal gland cancer	0.000254	0.00037	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF2—adrenal gland cancer	0.000253	0.00037	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GNAS—adrenal gland cancer	0.000251	0.000366	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000245	0.000357	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TERT—adrenal gland cancer	0.000244	0.000356	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—EGFR—adrenal gland cancer	0.000244	0.000356	CbGpPWpGaD
Amlexanox—FGF1—Disease—BRAF—adrenal gland cancer	0.000238	0.000348	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—adrenal gland cancer	0.000236	0.000345	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—BRAF—adrenal gland cancer	0.000233	0.000341	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000226	0.00033	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TERT—adrenal gland cancer	0.000226	0.00033	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BAD—adrenal gland cancer	0.000223	0.000326	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BAD—adrenal gland cancer	0.000213	0.00031	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TERT—adrenal gland cancer	0.000211	0.000308	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EGFR—adrenal gland cancer	0.000209	0.000304	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—adrenal gland cancer	0.000206	0.0003	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BRAF—adrenal gland cancer	0.000203	0.000297	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000197	0.000287	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BAD—adrenal gland cancer	0.000197	0.000287	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—adrenal gland cancer	0.000196	0.000286	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BRAF—adrenal gland cancer	0.000193	0.000282	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—adrenal gland cancer	0.000193	0.000281	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000188	0.000274	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTNNB1—adrenal gland cancer	0.000187	0.000272	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BAD—adrenal gland cancer	0.000183	0.000268	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—adrenal gland cancer	0.000181	0.000265	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BRAF—adrenal gland cancer	0.000179	0.000261	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—adrenal gland cancer	0.000175	0.000256	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000174	0.000253	CbGpPWpGaD
Amlexanox—FGF1—Disease—CTNNB1—adrenal gland cancer	0.000172	0.000251	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—adrenal gland cancer	0.000169	0.000247	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000169	0.000246	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BRAF—adrenal gland cancer	0.000167	0.000244	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—adrenal gland cancer	0.000148	0.000216	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000147	0.000214	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00014	0.000204	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—adrenal gland cancer	0.000136	0.000199	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—adrenal gland cancer	0.000134	0.000195	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000129	0.000189	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000121	0.000176	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—adrenal gland cancer	0.000116	0.00017	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—adrenal gland cancer	0.000112	0.000164	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—adrenal gland cancer	0.000111	0.000162	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—adrenal gland cancer	0.000103	0.00015	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—adrenal gland cancer	9.77e-05	0.000143	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—adrenal gland cancer	9.56e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—adrenal gland cancer	9.3e-05	0.000136	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—adrenal gland cancer	8.61e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—adrenal gland cancer	8.02e-05	0.000117	CbGpPWpGaD
